Related Experiment Videos
Ribozymes: RNA as a therapeutic agent
1Ferris State University College of Pharmacy, Big Rapids, Mich.
American Pharmacy
|January 1, 1995
Summary
Ribozymes (RZs) show promise as therapeutic agents due to high specificity and catalytic action. Further research is needed to overcome challenges before FDA approval, but their potential for targeted therapy is significant.
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Discovery
Background:
- Ribozymes (RZs) are RNA molecules with catalytic activity.
- Current therapeutic strategies face limitations that drive the search for novel agents.
- Antisense oligonucleotides (ASOs) are a comparable class of therapeutic agents.
Purpose of the Study:
- To evaluate the therapeutic potential of ribozymes (RZs).
- To highlight the advantages of RZs for targeted therapy.
- To assess the current status and future prospects of RZ technology.
Main Methods:
- Review of in vitro experimental results.
- Analysis of in vivo experimental findings.
- Assessment of RZ characteristics like specificity and catalytic mechanism.
Main Results:
- Experimental data from diverse in vitro and in vivo studies are encouraging.
- Ribozymes demonstrate high specificity of action.
- Ribozymes possess a catalytic mechanism enabling targeted therapy with minimal side effects.
Conclusions:
- Ribozyme technology offers significant advantages for therapeutic applications.
- Despite challenges, ongoing research is paving the way for RZ development.
- Ribozymes are poised to become valuable therapeutic agents in the future.